Literature DB >> 7118383

Solid-phase synthesis of chicken vasoactive intestinal peptide by a mild procedure using N alpha-9-fluorenylmethyloxycarbonyl amino acids.

R Colombo.   

Abstract

The octacosapeptide amide corresponding to the entire amino acid sequence of chicken vasoactive peptide (VIP) was assembled on a p-benzyloxybenzylamine resin support using the base-labile 9-fluorenylmethyloxycarbonyl as N alpha-protecting group, cleaved by mild acid treatment, and purified by gel-filtration and ion-exchange chromatography. The symmetrical anhydride coupling was employed and monitored by two independent methods, and acetic anhydride termination was incorporated to minimize formation of deletion peptides. The homogeneity of the final product, obtained in 18% yield, was assessed by t.l.c., disc electrophoresis, amino-terminal amino acid analysis, and amino acid analyses of acid and enzyme hydrolysates. The purified chicken VIP was shown to be active on gastric acid secretion and on pancreatic blood flow. Previously reported ring closure of the Asp-Asn unit seemed to be at a minimum, owing to the mild basic and acid treatments.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7118383     DOI: 10.1111/j.1399-3011.1982.tb03025.x

Source DB:  PubMed          Journal:  Int J Pept Protein Res        ISSN: 0367-8377


  2 in total

1.  An Smp43-Derived Short-Chain α-Helical Peptide Displays a Unique Sequence and Possesses Antimicrobial Activity against Both Gram-Positive and Gram-Negative Bacteria.

Authors:  Xudong Luo; Li Ding; Xiangdong Ye; Wen Zhu; Kaiyue Zhang; Fangyan Li; Huiwen Jiang; Zhiwen Zhao; Zongyun Chen
Journal:  Toxins (Basel)       Date:  2021-05-11       Impact factor: 4.546

2.  Fine-Tuning of Alkaline Residues on the Hydrophilic Face Provides a Non-toxic Cationic α-Helical Antimicrobial Peptide Against Antibiotic-Resistant ESKAPE Pathogens.

Authors:  Xudong Luo; Xiangdong Ye; Li Ding; Wen Zhu; Pengcheng Yi; Zhiwen Zhao; Huanhuan Gao; Zhan Shu; Shan Li; Ming Sang; Jue Wang; Weihua Zhong; Zongyun Chen
Journal:  Front Microbiol       Date:  2021-07-15       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.